লোডিং...
Successful Conversion Surgery Following Chylous Ascites After Nivolumab for Advanced Gastric Cancer
Case Report: A 75-year-old man who underwent nivolumab as the third-line chemotherapy for advanced gastric cancer had chylous ascites (CA) after the primary tumor shrank remarkably. Total parenteral nutrition and subcutaneous octreotide were initiated, and CA disappeared. Nivolumab was continued for...
সংরক্ষণ করুন:
| প্রকাশিত: | In Vivo |
|---|---|
| প্রধান লেখক: | , , , , , , , , , , , , |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
International Institute of Anticancer Research
2020
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7157868/ https://ncbi.nlm.nih.gov/pubmed/32111756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11810 |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|